Snapshot

The Priority Review pathway has been developed by the of Israel.

This pathway can be used where Medicinal products.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

MTIIR has a 270 calendar day review for new medicinal products which does not include information requests.